This week on Contemporary OB/GYN®: Jan. 31 to Feb. 4
A look at what's coming to Contemporary OB/GYN® this week.
Glenmark Pharmaceuticals gets FDA approval for generic MetroGel
The drug is used to treat bacterial vaginosis and is a generic version of Bausch Health US LLC’s MetroGel-Vaginal.
Balancing the rewards and risks of hormonal acne treatments
Julie Harper, MD, of the Dermatology and Skin Care Center of Birmingham, Alabama explained the use, side effects, and risks of spironolactone and oral contraceptives in a presentation at the current Maui Derm for Dermatologists meeting in Maui, Hawaii.
American Heart Month
February is American Heart Month. Each week, explore the facts, statistics, and resources available for women's heart health.
Coming soon
Statin use in midlife women
Risk assessment, lifestyle counseling, adverse effects, and medication management.
Coming soon
February 4: World Cancer Day
Friday marks World Cancer Day, an international awareness campaign led by the Union for International Cancer Control (IUCC). This year's theme is #CloseTheCareGap. Check back for toolkits, infographics, posters and more.
Coming soon
SMFM 2022 Annual Meeting
This week marks the beginning of the Society for Maternal-Fetal Medicine's 2022 Annual Meeting. Join us for the best of this year's virtual presentations, panel discussions, roundtables, and more.
Coming soon
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More
